0001209191-15-080389.txt : 20151116 0001209191-15-080389.hdr.sgml : 20151116 20151116182106 ACCESSION NUMBER: 0001209191-15-080389 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151116 FILED AS OF DATE: 20151116 DATE AS OF CHANGE: 20151116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lo Steven CENTRAL INDEX KEY: 0001501959 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 151236630 MAIL ADDRESS: STREET 1: C/O CORCEPT THERAPEUTICS STREET 2: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94010 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-11-16 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001501959 Lo Steven C/O CORCEPT THERAPEUTICS 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 0 1 0 0 SVP Oncology Common stock 2015-11-16 4 M 0 113960 3.51 A 113960 D Common stock 2015-11-16 4 M 0 286040 3.51 A 400000 D Common stock 2015-11-16 4 M 0 33333 2.70 A 433333 D Common stock 2015-11-16 4 M 0 64583 2.075 A 497916 D Common stock 2015-11-16 4 M 0 87500 1.92 A 585416 D Stock option 3.51 2015-11-16 4 M 0 113960 3.51 A 2020-09-23 Common stock 113960 0 D Stock option 3.51 2015-11-16 4 M 0 286040 3.51 A 2020-09-23 Common stock 286040 0 D Stock option 2.70 2015-11-16 4 M 0 33333 2.70 A 2022-10-09 Common stock 33333 0 D Stock option 2.075 2015-11-16 4 M 0 64583 2.075 A 2023-01-29 Common stock 64583 0 D Stock option 1.92 2015-11-16 4 M 0 87500 1.92 A 2023-11-18 Common stock 87500 0 D Exercise and hold. Fully exerciseable. /s/ Joseph K. Belanoff, CEO of Corcept Therapeutics Incorporated attorney-in-fact 2015-11-16